These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34538694)

  • 1. Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study.
    Elbasha EH; Choi Y; Daniels V; Goveia MG
    Vaccine; 2021 Oct; 39(42):6315-6321. PubMed ID: 34538694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.
    Hankin-Wei A; Rein DB; Hernandez-Romieu A; Kennedy MJ; Bulkow L; Rosenberg E; Trigg M; Nelson NP
    Vaccine; 2016 Jul; 34(35):4243-4249. PubMed ID: 27317459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
    Dhankhar P; Nwankwo C; Pillsbury M; Lauschke A; Goveia MG; Acosta CJ; Elbasha EH
    Value Health; 2015 Jun; 18(4):358-67. PubMed ID: 26091589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A vaccination coverage among adolescents (13-17 years) in the United States, 2008-2016.
    Nelson NP; Yankey D; Singleton JA; Elam-Evans LD
    Vaccine; 2018 Mar; 36(12):1650-1659. PubMed ID: 29449100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P; Tobe K; Abe M; Elbasha EH
    BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
    Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L
    Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong.
    Cheung TH; Cheng SSY; Hsu DC; Wong QW; Pavelyev A; Walia A; Saxena K; Prabhu VS
    Cost Eff Resour Alloc; 2021 Nov; 19(1):75. PubMed ID: 34801050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.
    Hutton DW; So SK; Brandeau ML
    Hepatology; 2010 Feb; 51(2):405-14. PubMed ID: 19839061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study.
    Quezada A; Baron-Papillon F; Coudeville L; Maggi L
    Rev Panam Salud Publica; 2008 May; 23(5):303-12. PubMed ID: 18510790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.
    Hayajneh WA; Daniels VJ; James CK; Kanıbir MN; Pilsbury M; Marks M; Goveia MG; Elbasha EH; Dasbach E; Acosta CJ
    BMC Infect Dis; 2018 Mar; 18(1):119. PubMed ID: 29514609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States.
    Daniels V; Prabhu VS; Palmer C; Samant S; Kothari S; Roberts C; Elbasha E
    Hum Vaccin Immunother; 2021 Jul; 17(7):1943-1951. PubMed ID: 33427033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
    Rein DB; Hicks KA; Wirth KE; Billah K; Finelli L; Fiore AE; Hoerger TJ; Bell BP; Armstrong GL
    Pediatrics; 2007 Jan; 119(1):e12-21. PubMed ID: 17200237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
    Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
    Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.
    Nelson NP; Weng MK; Hofmeister MG; Moore KL; Doshani M; Kamili S; Koneru A; Haber P; Hagan L; Romero JR; Schillie S; Harris AM
    MMWR Recomm Rep; 2020 Jul; 69(5):1-38. PubMed ID: 32614811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
    Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
    Nelson NP; Link-Gelles R; Hofmeister MG; Romero JR; Moore KL; Ward JW; Schillie SF
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(43):1216-1220. PubMed ID: 30383742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis a vaccination coverage among adolescents in the United States.
    Dorell CG; Yankey D; Byrd KK; Murphy TV
    Pediatrics; 2012 Feb; 129(2):213-21. PubMed ID: 22271690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.